✦ LIBER ✦

Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors

✍ Scribed by Nicolas Isambert, Pierre Fumoleau, Catherine Paul, Christophe Ferrand…

Book ID: 120679944
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 249 KB
Volume: 13
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-13-172

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of DMP 840 in pediatric pa

Phase I study of DMP 840 in pediatric patients with refractory solid tumors

✍ Joyce Thompson; Charles B. Pratt; Clinton F. Stewart; Loraine Avery; Laura Bowma 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 81 KB

463 POSTER Phase I study of sapacitabine

463 POSTER Phase I study of sapacitabine, an oral nucleoside analogue, in patients with refractory solid tumors or lymphomas

✍ A. Tolcher; E. Calvo; T. Carmona; A. Patnaik; K. Papadopoulos; A. Gianella-Borra 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 62 KB

A Phase I study of 9-nitrocamptothecin g

A Phase I study of 9-nitrocamptothecin given concurrently with capecitabine in patients with refractory, metastatic solid tumors

✍ M. Dror Michaelson; David P. Ryan; Charles S. Fuchs; Jeffrey G. Supko; Rocio Gar 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

## Abstract ## BACKGROUND 9‐Nitrocamptothecin (9‐NC) is an orally available camptothecin analog with antineoplastic activity that results from the inhibition of DNA topoisomerase I. Previous studies have suggested that it has significant clinical efficacy. The primary toxicities of 9‐NC include ga

A phase I trial of vinorelbine in combin

A phase I trial of vinorelbine in combination with mitoxantrone in patients with refractory solid tumors

✍ Nancy W. Peacock; Howard A. Burris; Veronique Dieras; Lon Smith; Gladys I. Rodri 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 87 KB

Phase I study of AG 331, a novel thymidy

Phase I study of AG 331, a novel thymidylate synthase inhibitor, in patients with refractory solid tumors

✍ Robert T. Koda; Agustin A. Garcia; Dhruba J. Chatterjee; Wen Yen Li; Deepika Par 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 153 KB

Phase I Study of Bevacizumab Plus Irinot

Phase I Study of Bevacizumab Plus Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors

✍ Okada, K.; Yamasaki, K.; Tanaka, C.; Fujisaki, H.; Osugi, Y.; Hara, J. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 360 KB